Brasilia, Jan 14 (Prensa Latina) Brazil adopted today for the first time in its history the use of a substance derived from marijuana for medical use, reported the National Health Surveillance Agency (ANVISA).
The drug, called Cannabidiol, is useful in the treatment of epilepsy, multiple sclerosis and schizophrenia, among other diseases.
The authorities reported that the consumption of this drug will not affect the health of the patients or make them addicted to the substance.
Brazil will ease the purchase abroad of the Cannabidiol, because there are not laboraties in its territory able to produce such medicine.
Of the 297 applications for the importation of the product received until the beginning of this month, Anvisa authorized 238, other 17 are in hold for the requirements on the part of the applicants and 34 are under review by the technical area.
Both, the doctors prescribing the medicine and the patients using it must be previously registered in a system that will be developed by the regional councils for Medicine.
http://www.plenglish.com/index.php?option=com_content&task=view&id=3443821&Itemid=1
http://www.therepublic.com/view/story/fce4270b554d4e008ae7df173eeb8387/LT--Brazil-Medical-Marijuana